| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.09 | 0.009 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |